Identifying BWH stage T2a cutaneous squamous cell carcinoma at risk for poor outcomes
Journal of the American Academy of Dermatology Dec 06, 2021
Gupta N, Weitzman RE, Murad F, et al. - Findings demonstrate an 8% likelihood of developing poor outcomes in Brigham and Women’s Hospital (BWH) T2a-high cutaneous squamous cell carcinomas (CSCCs).
In this 17-year retrospective multi-institutional cohort analysis of primary CSCC BWH T2a tumors, a predictive model based on tumor features was constructed to detect those at higher risk of poor outcomes.
Having 1 major and ≥1 minor criteria was most predictive of developing poor outcomes (AUC 0.53, C-statistic 0.60).
Major criteria included primary tumor diameter ≥40mm, invasion depth beyond subcutaneous fat, poor differentiation, and large caliber perineural invasion (PNI), and minor criteria were invasion depth in subcutaneous fat, moderate differentiation, small caliber PNI and lymphovascular invasion.
A sensitivity, specificity, and positive and negative predictive values of 7.7%, 97.4%, 33.3% and 86.1%, respectively, were demonstrated by the model.
In these tumors, 5-year cumulative incidence of poor outcomes was 8.0%, vs 2.8% in other T2a tumors (SHR 3.0).
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries